Harlan M. Krumholz, MD, SM, FACC, has been selected as the incoming editor-in-chief of JACC. He will begin transitioning into the position in January 2024, with his official term starting on July 1, 2024.
- December 07, 2023
Decoding Female-Specific Mechanisms in Cardiovascular Disease: A Captivating Conversation with Dr. Lauren Biwer
Interview with Lauren Biwer
- December 04, 2023Source: Yahoo!
Rohan Khera, MD, assistant professor of medicine (cardiovascular medicine), weighs in on the importance of including Black women and other groups in clinical trials.
- December 01, 2023Source: Scientific American
Yale School of Medicine's Akiko Iwasaki, PhD, and Erica Spatz, MD, MHS, weigh in on the declining rates of long COVID.
- November 30, 2023
Welcome Incoming Cardiovascular Medicine Fellows!
- November 27, 2023
A collaborative study led by Yale researchers reports the many gene expression changes that develop over the course of a neurodegenerative disorder called spinocerebellar ataxia type 1, shedding light on its progression.
- November 15, 2023
Anti-obesity Medication Semaglutide (Wegovy®) Could Benefit Millions of Americans With Obesity and Cardiovascular Disease
The medication has the potential to markedly reduce the risk of heart attacks and other heart-related conditions among millions of Americans with obesity who have also been diagnosed with cardiovascular disease, a Yale study shows.
- November 14, 2023Source: Health
Harlan Krumholz, MD, SM, Harold H. Hines, Jr. Professor of Medicine (Cardiology), comments on the impact of cardiovascular health on aging.
- November 11, 2023Source: The New York Times
Yuan Lu, ScD, assistant professor of medicine (cardiovascular medicine), comments on a study that shows Wegovy reduced the risk of heart attack and stroke in some patients.
- November 02, 2023
Using a new computational method based on a causal inference framework, CINEMA-OT, the Yale team studied how individual immune cells react to combinations of cytokines, or small proteins released by cells that regulate inflammation. They discovered that certain cytokines have a synergistic effect, inducing unique gene activation programs compared to their individual effects. This cryptography of cytokine signals acts as a language, instructing immune cells.